CAH CARDINAL HEALTH INC

NYSE cardinalhealth.com


$ 190.82 $ 0.93 (0.49 %)    

Friday, 31-Oct-2025 15:59:58 EDT
QQQ $ 633.35 $ 0.00 (0 %)
DIA $ 475.94 $ 0.00 (0 %)
SPY $ 684.64 $ 0.00 (0 %)
TLT $ 90.02 $ 0.00 (0 %)
GLD $ 368.42 $ 0.00 (0 %)
$ 190.77
$ 192.93
$ 187.50 x 10
$ 192.85 x 53
-- - --
$ 109.06 - $ 197.67
4,080,725
na
45.33B
$ 0.63
$ 28.42
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 10-30-2025 09-30-2025 10-Q
2 08-12-2025 06-30-2025 10-K
3 05-01-2025 03-31-2025 10-Q
4 01-30-2025 12-31-2024 10-Q
5 11-01-2024 09-30-2024 10-Q
6 08-14-2024 06-30-2024 10-K
7 05-02-2024 03-31-2024 10-Q
8 02-01-2024 12-31-2023 10-Q
9 11-03-2023 09-30-2023 10-Q
10 08-15-2023 06-30-2023 10-K
11 05-04-2023 03-31-2023 10-Q
12 02-02-2023 12-31-2022 10-Q
13 11-04-2022 09-30-2022 10-Q
14 08-11-2022 06-30-2022 10-K
15 05-05-2022 03-31-2022 10-Q
16 02-03-2022 12-31-2021 10-Q
17 11-09-2021 09-30-2021 10-Q
18 08-16-2021 06-30-2021 10-K
19 05-06-2021 03-31-2021 10-Q
20 02-05-2021 12-31-2020 10-Q
21 11-05-2020 09-30-2020 10-Q
22 08-13-2020 06-30-2020 10-K
23 05-11-2020 03-31-2020 10-Q
24 02-06-2020 12-31-2019 10-Q
25 11-07-2019 09-30-2019 10-Q
26 08-20-2019 06-30-2019 10-K
27 05-09-2019 03-31-2019 10-Q
28 02-07-2019 12-31-2018 10-Q
29 11-08-2018 09-30-2018 10-Q
30 08-22-2018 06-30-2018 10-K
31 05-09-2018 03-31-2018 10-Q
32 02-08-2018 12-31-2017 10-Q
33 11-07-2017 09-30-2017 10-Q
34 08-10-2017 06-30-2017 10-K
35 05-02-2017 03-31-2017 10-Q
36 02-07-2017 12-31-2016 10-Q
37 11-02-2016 09-30-2016 10-Q
38 08-12-2016 06-30-2016 10-K
39 05-03-2016 03-31-2016 10-Q
40 02-02-2016 12-31-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 citigroup-maintains-neutral-on-cardinal-health-raises-price-target-to-190

Citigroup analyst Daniel Grosslight maintains Cardinal Health (NYSE:CAH) with a Neutral and raises the price target from $16...

 ubs-maintains-buy-on-cardinal-health-raises-price-target-to-220

UBS analyst Kevin Caliendo maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $185 to $220.

 evercore-isi-group-maintains-outperform-on-cardinal-health-raises-price-target-to-220

Evercore ISI Group analyst Elizabeth Anderson maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price ta...

 marjorie-taylor-greene-buys-netflix-stock-after-downbeat-q3-earnings-expands-big-tech-bet

MTG "buys the dip" on Netflix (NFLX) stock after a bad Q3 report. See all 14 of her new purchases, including MSFT and A...

 meta-tumbles-10-google-marks-historic-rally-whats-moving-markets-thursday

Wall Street saw a cautious tone on Thursday as major tech-heavy indexes edged lower, weighed down by mixed earnings from the me...

 cardinal-health-rallies-as-strong-start-to-2026-fuels-higher-earnings-guidance

Cardinal Health shares rise as Q1 earnings beat estimates, revenue jumps 22%, and the company lifts its 2026 earnings and cash ...

 cardinal-health-raises-fy2026-adj-eps-guidance-from-930-950-to-965-985-vs-943-est

Cardinal Health (NYSE:CAH) raises FY2026 Adj EPS guidance from $9.30-$9.50 to $9.65-$9.85 vs $9.43 analyst estimate..

 cardinal-health-q1-adj-eps-255-beats-218-estimate-sales-64009b-beat-59197b-estimate

Cardinal Health (NYSE:CAH) reported quarterly earnings of $2.55 per share which beat the analyst consensus estimate of $2.18 by...

 cardinal-health-plans-to-establish-distribution-center-in-indianapolis-indiana

DUBLIN, Ohio, Sept. 30, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced plans for a new flagship forward distr...

Core News & Articles

https://www.youtube.com/watch?v=2KW1mVChh-c&feature=youtu.be

 wells-fargo-maintains-overweight-on-cardinal-health-raises-price-target-to-185

Wells Fargo analyst Stephen Baxter maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION